[1]刘金凤 付华 曾锐 杨庆 胡宏德 崔凯军.心房颤动导管消融后日间病房模式的安全性及有效性评价[J].心血管病学进展,2025,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2025.03.018]
　LIU Jinfeng,FU Hua,ZENG Rui,et al.Evaluation of Safety and Effectiveness of SameDay Discharge After Atrial Fibrillation Catheter Ablation[J].Advances in Cardiovascular Diseases,2025,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2025.03.018]
点击复制

心房颤动导管消融后日间病房模式的安全性及有效性评价()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年3期
页码:
278
栏目:
论著
出版日期:
2025-03-25

文章信息/Info

Title:
Evaluation of Safety and Effectiveness of SameDay Discharge After Atrial Fibrillation Catheter Ablation
作者:
刘金凤 付华 曾锐 杨庆 胡宏德 崔凯军
(四川大学华西医院,四川 成都 610041)
Author(s):
LIU Jinfeng; FU Hua; ZENG Rui; YANG Qing; HU Hongde; CUI Kaijun
(West China Hospital of Sichuan University,Chengdu 610041,Sichuan,China)
关键词:
心房颤动; 导管消融; 日间病房模式; 常规病房模式; 并发症
Keywords:
Atrial fibrillation; Catheter ablation; Sameday discharge; Overnight stay; Complication
DOI:
10.16806/j.cnki.issn.1004-3934.2025.03.018
摘要:
目的 心房颤动（房颤）消融术后患者住院观察时间常规较长，本研究比较了房颤消融后日间病房模式（SDD）及常规病房模式（ONS）方案的安全性、有效性及SDD方案的成本效益。方法 对2020年1月 —2023年12月接受房颤消融治疗的SDD和ONS方案患者进行单中心回顾性研究。收集患者基线、消融1年后成功率及并发症的发生率、住院总费用等，并发症主要包括死亡、心脏压塞、脑血管意外、需干预的血肿、不需干预的血肿、肺静脉狭窄、膈肌麻痹或心房食管瘘形成；同时对SDD组和ONS组患者住院费用和有效性进行对比，并对两组患者干预前后房颤患者生活质量量表（AFEQT）评分进行比较。结果 共纳入844例 房颤患者，其中SDD方案413例，ONS方案431例。两组患者的平均年龄存在显著性差异（P＜0.05）；房颤消融出院后1年内，SDD组有3例（0.73%）出现并发症，ONS组有11例（2.55%）出现并发症，SDD组并发症发生率显著低于ONS组（P＜0.05）。SDD组患者的平均住院费用显著低于ONS组（P＜0.01），SDD组患者的有效率显著高于ONS组（P＜0.01）；SDD组患者房颤消融前后AFEQT评分差值显著低于ONS组（P＜0.01）。结论 患者可在导管消融后 SDD下安全出院，SDD是安全、有效和成本效益高的方案，但SDD方案的普及，仍需在更大人群中进行评估。
Abstract:
Objective The hospitalization observation time of patients with atrial fibrillation(AF) after ablation is usually longer. This study compared the safety,effectiveness,and cost-effectiveness of same‐day discharge(SDD) protocol and overnight stay(ONS) protocol after AF ablation. Methods A single center retrospective study was conducted on SDD and ONS protocol patients who received AF ablation treatment from January 2020 to December 2023. The patient baseline,success rate and incidence of complications after 1 year of ablation,total hospitalization costs,etc were collected. Complications mainly include death,cardiac tamponade,cerebrovascular accident,hematoma requiring intervention,hematoma not requiring intervention,pulmonary vein stenosis,diaphragmatic paralysis,or formation of atrial esophageal fistula. At the same time,the hospitalization costs and effectiveness of patients in the SDD group and ONS group were compared,and the AFEQT scores of AF patients before and after intervention were compared between the two groups of patients. Results A total of 844 patients with AF were included,including 413 with SDD protocol and 431 with ONS protocol. There was a significant difference in the average age between the two groups of patients ( P＜0.05). Within 1 year after discharge from AF ablation,there were 3 cases (0.73%) of complications in the SDD group and 1 1 cases( 2.55%) in the ONS group. The incidence of complications in the SDD group was significantly lower than that in the ONS group (P＜0.05). The average hospitalization cost of patients in the SDD group was significantly lower than that in the ONS group ( P＜0.01),and the effective rate of patients in the SDD group was significantly higher than that in the ONS group(P＜0.01). The difference in AFEQT scores before and after surgery in the SDD group was significantly lower than that in the ONS group(P＜0.01). The mean hospital costs of patients in the SDD group were significantly reduced compared to those in the ONS group (P＜0.01). The AFEQT score showed that the difference in scores befor e and after surgery in SDD patients was significantly lower than that in ONS patients (P＜0.01). Conclusion Patients can be safely discharged after catheter ablation using SDD protocol,which is a safe,effective,and cost-effective option. However,the widespread adoption of SDD protocol still needs to be evaluated in a larger population

参考文献/References:

[1] Zylla MM,Imberti JF,Leyva F,et al. Same-day discharge vs. overnight stay following catheter ablation for atrial fibrillation:a comprehensive review and meta-analysis by the European Heart Rhythm Association Health Economics Committee[J]. Europace,2024,26(8):euae200.
[2] Benjamin LF,Shu Y,David S,et al. Feasibility and safety of same-day discharge and shortened bedrest after atrial fibrillation ablation[J]. J Interv Card Electrophysiol,2022,65(1):209-217.
[3] Sangrigoli R,Harding J,Venkataraman G,et al. Randomized prospective evaluation of same-day discharge after cryoballoon ablation of atrial fibrillation:results of the EASY PVI study[J]. J Interv Card Electrophysiol,2023,66(7):1601-1607.
[4] Kowalski M,Parikh V,Salcido JR,et al. Same-day discharge after cryoballoon ablation of atrial fibrillation:a multicenter experience[J]. J C ardiovasc E lectrophysiol,2020,32(2):183-190.
[5] Deyell MW,Leather RA,Macle L,et al. Efficacy and safety of same-day discharge for atrial fibrillation ablation[J]. JACC Clin Electrophysiol,2020,6(6):609-619.
[6] 郝拉娣,何平. 图表中平均数差异显著性检验结果的规范表达[J]. 编辑学报,2008,20(2):120-122.
[7] Zenger B,Torre M,Zhang Y. Comprehensive analysis of same day discharge after atrial fibrillation ablation:clinical,cost,and patient reported outcomes[J]. J Cardiovasc Electrophysiol,2024,35(8):1570-1578.
[8] Castro-Urda V,Segura-Dominguez M,Jiménez-Sánchez D,et al. Efficacy and safety of Proglide use and early discharge after atrial fibrillation ablation compared to standard approach. PROFA trial[J]. Pacing Clin Electrophysiol,2023,46(7):598-606.
[9] Deyell MW,Hoskin K,Forman J,et al. Same-day discharge for atrial fibrillation ablation:outcomes and impact of ablation modality[J]. Europace,2023,25(2):400-407.
[10] Paul Nordin A,Drca N,Insulander P,et al. Low incidence of major complications after the first six hours post atrial fibrillation ablation:is same-day discharge safe and feasible in most patients?[J]. J Cardiovasc Electrophysiol,2021,32(11):2953-2960.
[11] Tang PT,Davies M,Bashir Y,et al. Efficacy and safety of same-day discharge after atrial fibrillation ablation compared with post-procedural overnight stay:a systematic review and meta-analysis[J]. Europace,2022,24(10):1569-1584.
[12] 莫远明,卢瑞鸿,林冬,等. 一体化日间手术信息平台设计与建设探索[J]. 现代医院,2020,20(11):4.
[13] Rajendra A,Hunter TD,Morales G,et al. Prospective implementation of a same-day discharge protocol for catheter ablation of paroxysmal atrial fibrillation[J]. J Interv Card Electrophysiol,2020,62(2):419-425.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
　HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(3):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
　DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(3):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
　ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
　ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
　HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
　WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
　XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
　ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(3):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
　WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(3):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
　ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(3):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
　WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(3):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
[12]赵磊 梁兆光.导管消融术后心房颤动复发的危险因素及预防[J].心血管病学进展,2019,(5):766.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
　ZHAO LeiLIANG Zhaoguang.Risk Factors and Prevention of Atrial Fibrillation Recurrence after Catheterablation[J].Advances in Cardiovascular Diseases,2019,(3):766.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
[13]辛小宇 梁兆光.心房颤动导管消融围术期抗凝治疗研究进展[J].心血管病学进展,2020,(8):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
　XIN XiaoyuLIANG Zhaoguang.Perioperative Anticoagulation for Atrial Fibrillation Catheter Ablation[J].Advances in Cardiovascular Diseases,2020,(3):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
[14]赵灿 吴永全.基于环肺静脉隔离的房颤导管消融策略选择治疗进展[J].心血管病学进展,2020,(12):1234.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.003]
　ZHAO Can,WU Yongquan.Catheter Ablation Strategies for Atrial Fibrillation Based on Circumferential Pulmonary Vein Isolation[J].Advances in Cardiovascular Diseases,2020,(3):1234.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.003]
[15]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
　LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(3):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[16]白金龙 李洪仕 蔡衡.非瓣膜性心房颤动导管消融术后抗凝策略的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.201.01.000]
[17]那丞 黄织春.干预自主神经对心房颤动影响的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
　NA Cheng,HUANG Zhichun.Effect of Autonomic Nerve Intervention on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(3):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[18]徐尧 蔡衡 李洪仕.心房颤动合并心力衰竭的导管消融治疗[J].心血管病学进展,2021,(4):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
　XU Yao,CAI Heng,LI Hongshi.Role of Radiofrequency Ablation in Patients with Atrial Fibrillation and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(3):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
[19]袁明 谢瑞芹.导管消融对心房颤动患者生活质量影响的研究进展[J].心血管病学进展,2021,(10):884.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.005]
　YUAN MingXIE Ruiqin.Effect of Catheter Ablation on Quality of Life in patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(3):884.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.005]
[20]邹永伟 胡小恋.左房低电压与心房颤动相关性的研究进展[J].心血管病学进展,2022,(3):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
　ZHOU Yongwei,H U Xiaolian.The Correlation Between Left Atrial Low-Voltage Area and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(3):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]

更新日期/Last Update: 2025-04-29